Authors
Loading...
Bioinformatics methods reveal CXCL2 as a key biomarker for diabetic nephropathy, suggesting potential treatment pathways.
Miao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: